PHSRX
Price
$55.75
Change
-$0.13 (-0.23%)
Updated
Jun 12 closing price
Net Assets
1.48B
SHSAX
Price
$63.86
Change
-$0.05 (-0.08%)
Updated
Jun 12 closing price
Net Assets
5.93B
Interact to see
Advertisement

PHSRX vs SHSAX

Header iconPHSRX vs SHSAX Comparison
Open Charts PHSRX vs SHSAXBanner chart's image
PHSRX vs SHSAX Comparison Chart in %
View a ticker or compare two or three
VS
PHSRX vs. SHSAX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHSRX is a Hold and SHSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 5.93B vs. PHSRX (1.48B). SHSAX pays higher dividends than PHSRX: SHSAX (0.27) vs PHSRX (0.18). PHSRX was incepted earlier than SHSAX: PHSRX (23 years) vs SHSAX (27 years). PHSRX (1.29) is less costly to investors than SHSAX (1.09). PHSRX is a more actively managed with annual turnover of: 67.00 vs. SHSAX (43.00). PHSRX has a lower initial minimum investment than SHSAX: PHSRX (0) vs SHSAX (1000). PHSRX annual gain was more profitable for investors over the last year : 12.35 vs. SHSAX (3.33). PHSRX return over 5 years is better than : -4.17 vs. SHSAX (-17.60).
PHSRXSHSAXPHSRX / SHSAX
Total Expense Ratio1.291.09118%
Annual Report Gross Expense Ratio1.291.09118%
Fund Existence23 years27 years-
Gain YTD0.036-1.344-3%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B5.93B25%
Annual Yield % from dividends0.180.2767%
Returns for 1 year12.353.33371%
Returns for 3 years9.12-2.27-402%
Returns for 5 years-4.17-17.6024%
Returns for 10 years5.4039.1714%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RUSHB70.920.71
+1.01%
Rush Enterprises
HFWA29.040.22
+0.76%
Heritage Financial Corp
FDX338.310.31
+0.09%
FedEx Corp
WALD1.86N/A
N/A
Waldencast plc
ALLR1.43-0.12
-7.74%
Allarity Therapeutics Inc